| Nov 15 2009 |
XTEN Data from Amunix and Versartis Featured in Nature Biotechnology as a Novel Platform for Increasing Serum Half-life of Protein Therapeutics |
| Sep 23 2009 |
Versartis Presents Preclinical Data for Novel Type 2 Diabetes Drug |
| Sep 14 2009 |
Versartis to Provide Update on Product Pipeline at Two Technology Conferences |
| Aug 17 2009 |
SynCo Bio Partners to Manufacture Versartis Novel Drug for Type 2 Diabetes |
| Jun 10 2009 |
Versartis Presents Positive Preclinical Data on Two Product Candidates at ENDO 09 |
| Jun 05 2009 |
Versartis Publishes Preclinical Abstracts for Two Product Candidates at 2009 American Diabetes Association Scientific Sessions |
| Jun 02 2009 |
Versartis, Inc. Completes Series A Funding of $11 Million [€7.9 M] in a Joint Venture between Index Ventures and Amunix, Inc. |
